The company reported second-quarter adjusted earnings per share of $1.92, beating the analyst consensus estimate of $1.66.

Kimberly-Clark's recent Q2 results showed strong organic sales growth and an improved outlook despite headline revenue misses ...

Kimberly-Clark Corp (KMB) reports its strongest quarterly sales growth in five years, driven by innovation and strategic ...

Andrex-maker Kimberly Clark notched up its strongest volume growth in five years through the second quarter leading it to ...

KMB beats second-quarter estimates despite sales dip, driven by five-year high volume growth, and raises 2025 outlook.

Adjusted free cash flow is still seen at around $2 billion this year. (Bloomberg) -- Kimberly-Clark Corp. raised its ...

Clark's second-quarter organic sales rose as the Kleenex tissue maker recorded its best volume growth in five years amid ...

Kimberly-Clark's Q2 results reveal organic sales growth, the highest volume growth in 5 years, and strategic actions for ...

The Kleenex-maker estimated a $170 million loss in tariff-related costs for the year – a stark decrease from the estimated ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

A proposed class of consumers failed to plausibly allege the Kimberly-Clark Corp. misled them or intentionally omitted ...

(Reuters) -Kimberly-Clark on Friday posted a rise in second-quarter organic sales and beat profit estimates, led by steady ...